+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Monocyte Activation Tests: Global Strategic Business Report

  • PDF Icon

    Report

  • 244 Pages
  • December 2023
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140637

Quick Summary:

In the ever-evolving healthcare industry, staying ahead of key trends and innovations is paramount. The global Monocyte Activation Tests market is steadily gaining traction, triggering a need for comprehensive insights into this emerging sector. Predicted to escalate from US$10.8 Million in 2022 to a robust US$29.8 Million by 2030, this market presents an array of opportunities for informed decision-making and strategic investments.

Detailed analysis of the significant segments and geographies, such as the high-potential U.S. and Chinese markets, is paramount in today’s competitive landscape. Our meticulous report also delves into the performance of key competitors - from Becton, Dickinson & Company to Thermo Fisher Scientific, Inc. Capitalize on our exclusive digital resources and benefit from complimentary updates for one year, to stay informed about all essential developments. This market research report is your roadmap to navigate the promising arena of Monocyte Activation Tests with confidence and acumen.

Global Monocyte Activation Tests Market to Reach $29.8 Million by 2030

The global market for Monocyte Activation Tests estimated at US$10.8 Million in the year 2022, is projected to reach a revised size of US$29.8 Million by 2030, growing at a CAGR of 13.5% over the analysis period 2022-2030. Monocyte Activation Test Kits, one of the segments analyzed in the report, is projected to record 14.7% CAGR and reach US$16.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Reagents segment is readjusted to a revised 12.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.3 Million, While China is Forecast to Grow at 12.9% CAGR

The Monocyte Activation Tests market in the U.S. is estimated at US$3.3 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$5.1 Million by the year 2030 trailing a CAGR of 12.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.1% and 11.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.

Select Competitors (Total 41 Featured) -

  • Becton, Dickinson & Company
  • Charles River Laboratories International, Inc.
  • Lonza Group AG
  • Merck KgaA
  • Microcoat Biotechnologie GmbH
  • Sanquin
  • Solvias AG
  • Thermo Fisher Scientific, Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and the publisher's Research Platform
  • Complimentary updates for one year

Frequently Asked Questions about the Global Market for Monocyte Activation Tests

What is the estimated value of the Global Market for Monocyte Activation Tests?

The Global Market for Monocyte Activation Tests was estimated to be valued at $10.8 Million in 2022.

What is the growth rate of the Global Market for Monocyte Activation Tests?

The growth rate of the Global Market for Monocyte Activation Tests is 13.5%, with an estimated value of $29.8 Million by 2030.

What is the forecasted size of the Global Market for Monocyte Activation Tests?

The Global Market for Monocyte Activation Tests is estimated to be worth $29.8 Million by 2030.

Who are the key companies in the Global Market for Monocyte Activation Tests?

Key companies in the Global Market for Monocyte Activation Tests include Becton, Dickinson & Company, Charles River Laboratories International, Inc., Lonza Group AG, Merck KgaA, Microcoat Biotechnologie GmbH, Sanquin, Solvias AG and Thermo Fisher Scientific, Inc..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Monocyte Activation Tests - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Monocyte Activation Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 2: World 8-Year Perspective for Monocyte Activation Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
  • Table 3: World Recent Past, Current & Future Analysis for Monocyte Activation Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 4: World 8-Year Perspective for Monocyte Activation Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 6: World 8-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Blood Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 8: World 8-Year Perspective for Blood Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 9: World Recent Past, Current & Future Analysis for Peripheral Blood Mononuclear Cell (PBMC) Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 10: World 8-Year Perspective for Peripheral Blood Mononuclear Cell (PBMC) Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Cell Line Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 12: World 8-Year Perspective for Cell Line Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 14: World 8-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 15: World Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 16: World 8-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 18: World 8-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Other End-Use Industries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 20: World 8-Year Perspective for Other End-Use Industries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 21: World Monocyte Activation Tests Market Analysis of Annual Sales in US$ for Years 2014 through 2030
III. MARKET ANALYSIS
  • UNITED STATES
  • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 22: USA Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 23: USA 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
  • Table 24: USA Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 25: USA 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 27: USA 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • CANADA
  • Table 28: Canada Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 29: Canada 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
  • Table 30: Canada Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 31: Canada 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 33: Canada 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • JAPAN
  • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 34: Japan Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 35: Japan 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
  • Table 36: Japan Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 37: Japan 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 39: Japan 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • CHINA
  • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 40: China Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 41: China 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
  • Table 42: China Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 43: China 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 45: China 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • EUROPE
  • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 46: Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 47: Europe 8-Year Perspective for Monocyte Activation Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
  • Table 48: Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 49: Europe 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 51: Europe 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
  • Table 52: Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 53: Europe 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • FRANCE
  • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 54: France Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 55: France 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
  • Table 56: France Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 57: France 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
  • Table 58: France Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 59: France 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • GERMANY
  • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 60: Germany Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 61: Germany 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
  • Table 62: Germany Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 63: Germany 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
  • Table 64: Germany Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 65: Germany 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • ITALY
  • Table 66: Italy Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 67: Italy 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
  • Table 68: Italy Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 69: Italy 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
  • Table 70: Italy Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 71: Italy 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • UNITED KINGDOM
  • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 72: UK Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 73: UK 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
  • Table 74: UK Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 75: UK 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
  • Table 76: UK Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 77: UK 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • REST OF EUROPE
  • Table 78: Rest of Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 79: Rest of Europe 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
  • Table 80: Rest of Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 81: Rest of Europe 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
  • Table 82: Rest of Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 83: Rest of Europe 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • ASIA-PACIFIC
  • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 84: Asia-Pacific Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 85: Asia-Pacific 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
  • Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 87: Asia-Pacific 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
  • Table 88: Asia-Pacific Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 89: Asia-Pacific 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • REST OF WORLD
  • Table 90: Rest of World Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 91: Rest of World 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
  • Table 92: Rest of World Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 93: Rest of World 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
  • Table 94: Rest of World Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 95: Rest of World 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Becton, Dickinson & Company
  • Charles River Laboratories International, Inc.
  • Lonza Group AG
  • Merck KgaA
  • Microcoat Biotechnologie GmbH
  • Sanquin
  • Solvias AG
  • Thermo Fisher Scientific, Inc.